Marilyn A. Isbell

725 total citations
13 papers, 622 citations indexed

About

Marilyn A. Isbell is a scholar working on Biochemistry, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Marilyn A. Isbell has authored 13 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biochemistry, 6 papers in Pathology and Forensic Medicine and 5 papers in Pharmacology. Recurrent topics in Marilyn A. Isbell's work include Eicosanoids and Hypertension Pharmacology (7 papers), Cannabis and Cannabinoid Research (4 papers) and Alcohol Consumption and Health Effects (4 papers). Marilyn A. Isbell is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (7 papers), Cannabis and Cannabinoid Research (4 papers) and Alcohol Consumption and Health Effects (4 papers). Marilyn A. Isbell collaborates with scholars based in United States. Marilyn A. Isbell's co-authors include Kasem Nithipatikom, William B. Campbell, John R. Falck, Michael P. Endsley, Garrett J. Gross, Jeannine Moore, Yoshiki Iwamoto, Cecilia J. Hillard, Eric R. Gross and Craig E. Wheelock and has published in prestigious journals such as Circulation Research, Cancer Research and Analytical Biochemistry.

In The Last Decade

Marilyn A. Isbell

13 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn A. Isbell United States 11 293 262 176 159 126 13 622
D. Sudarshan Reddy United States 10 168 0.6× 224 0.9× 168 1.0× 103 0.6× 70 0.6× 10 458
Virgile Visentin France 16 158 0.5× 177 0.7× 146 0.8× 56 0.4× 374 3.0× 32 779
Fanrong Yao United States 16 106 0.4× 81 0.3× 128 0.7× 70 0.4× 148 1.2× 35 615
Lili Yang China 15 158 0.5× 51 0.2× 177 1.0× 151 0.9× 219 1.7× 26 710
Alicia Sánchez-Mendoza Mexico 17 60 0.2× 182 0.7× 193 1.1× 66 0.4× 252 2.0× 47 777
Seyhan Şahan-Fırat Türkiye 17 67 0.2× 250 1.0× 139 0.8× 58 0.4× 268 2.1× 40 692
Todd R. Harris United States 18 86 0.3× 799 3.0× 369 2.1× 243 1.5× 251 2.0× 28 1.1k
Fabiano E. Xavier Brazil 19 101 0.3× 208 0.8× 228 1.3× 27 0.2× 196 1.6× 45 932
Takanori Hashizume Japan 18 104 0.4× 179 0.7× 172 1.0× 240 1.5× 179 1.4× 24 1.0k
Malek Kechrid United States 5 167 0.6× 29 0.1× 82 0.5× 208 1.3× 232 1.8× 9 712

Countries citing papers authored by Marilyn A. Isbell

Since Specialization
Citations

This map shows the geographic impact of Marilyn A. Isbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn A. Isbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn A. Isbell more than expected).

Fields of papers citing papers by Marilyn A. Isbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn A. Isbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn A. Isbell. The network helps show where Marilyn A. Isbell may publish in the future.

Co-authorship network of co-authors of Marilyn A. Isbell

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn A. Isbell. A scholar is included among the top collaborators of Marilyn A. Isbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn A. Isbell. Marilyn A. Isbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gauthier, Kathryn M., Marilyn A. Isbell, John D. Imig, et al.. (2011). Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. American Journal of Physiology-Renal Physiology. 301(4). F765–F772. 3 indexed citations
2.
Nithipatikom, Kasem, Marilyn A. Isbell, Michael P. Endsley, Jeffrey Woodliff, & William B. Campbell. (2010). Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. Prostaglandins & Other Lipid Mediators. 94(1-2). 34–43. 38 indexed citations
3.
Cui, Lijie, et al.. (2008). Structural characterization of monohydroxyeicosatetraenoic acids and dihydroxy- and trihydroxyeicosatrienoic acids by ESI-FTICR. Journal of the American Society for Mass Spectrometry. 19(4). 569–585. 14 indexed citations
4.
Endsley, Michael P., Marilyn A. Isbell, Craig E. Wheelock, et al.. (2007). Diverse roles of 2‐arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12‐lipoxygenase metabolism. International Journal of Cancer. 121(5). 984–991. 47 indexed citations
5.
Nithipatikom, Kasem, Jeannine Moore, Marilyn A. Isbell, John R. Falck, & Garrett J. Gross. (2006). Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology. 291(2). H537–H542. 76 indexed citations
6.
Nithipatikom, Kasem, Michael P. Endsley, Jeannine Moore, et al.. (2005). Effects of selective inhibition of cytochrome P-450 ω-hydroxylases and ischemic preconditioning in myocardial protection. American Journal of Physiology-Heart and Circulatory Physiology. 290(2). H500–H505. 42 indexed citations
7.
Nithipatikom, Kasem, Michael P. Endsley, Marilyn A. Isbell, et al.. (2005). A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochemical and Biophysical Research Communications. 332(4). 1028–1033. 42 indexed citations
8.
Nithipatikom, Kasem, Marilyn A. Isbell, William A. See, & William B. Campbell. (2005). Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. Cancer Letters. 233(2). 219–225. 41 indexed citations
9.
Nithipatikom, Kasem, Eric R. Gross, Michael P. Endsley, et al.. (2004). Inhibition of Cytochrome P450ω-Hydroxylase. Circulation Research. 95(8). e65–71. 95 indexed citations
10.
Nithipatikom, Kasem, Michael P. Endsley, Marilyn A. Isbell, et al.. (2004). 2-Arachidonoylglycerol. Cancer Research. 64(24). 8826–8830. 112 indexed citations
11.
12.
Patel, Hemal H., Ryan M. Fryer, Eric R. Gross, et al.. (2003). 12-Lipoxygenase in Opioid-Induced Delayed Cardioprotection. Circulation Research. 92(6). 676–682. 37 indexed citations
13.
Nithipatikom, Kasem, et al.. (2002). Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clinical & Experimental Metastasis. 19(7). 593–601. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Sudarshan Reddy Breakdown of academic impact, for papers by Virgile Visentin Breakdown of academic impact, for papers by Fanrong Yao Breakdown of academic impact, for papers by Lili Yang Breakdown of academic impact, for papers by Alicia Sánchez-Mendoza Breakdown of academic impact, for papers by Seyhan Şahan-Fırat Breakdown of academic impact, for papers by Todd R. Harris Breakdown of academic impact, for papers by Fabiano E. Xavier Breakdown of academic impact, for papers by Takanori Hashizume Breakdown of academic impact, for papers by Malek Kechrid
Rankless by CCL
2026